303 related articles for article (PubMed ID: 26812081)
21. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing.
Boskovic R; Einarson A; Maltepe C; Wolpin J; Koren G
J Obstet Gynaecol Can; 2003 Oct; 25(10):830-3. PubMed ID: 14532951
[TBL] [Abstract][Full Text] [Related]
22. Nausea and vomiting of pregnancy: A study with pregnancy-unique quantification of emesis questionnaire.
Ellilä P; Laitinen L; Nurmi M; Rautava P; Koivisto M; Polo-Kantola P
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():60-67. PubMed ID: 30243227
[TBL] [Abstract][Full Text] [Related]
23. Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects.
Blum RA; Majumdar A; McCrea J; Busillo J; Orlowski LH; Panebianco D; Hesney M; Petty KJ; Goldberg MR; Murphy MG; Gottesdiener KM; Hustad CM; Lates C; Kraft WK; Van Buren S; Waldman SA; Greenberg HE
Clin Ther; 2003 May; 25(5):1407-19. PubMed ID: 12867217
[TBL] [Abstract][Full Text] [Related]
24. Transdermal granisetron.
Duggan ST; Curran MP
Drugs; 2009; 69(18):2597-605. PubMed ID: 19943709
[TBL] [Abstract][Full Text] [Related]
25. [The use of granisetron per os in radiotherapy-induced emesis].
Krengli M; Lazzari R; Manara M
Minerva Med; 1996 Dec; 87(12):605-8. PubMed ID: 9064597
[TBL] [Abstract][Full Text] [Related]
26. Vitamin B₆ supplementation in pregnant women with nausea and vomiting.
Wibowo N; Purwosunu Y; Sekizawa A; Farina A; Tambunan V; Bardosono S
Int J Gynaecol Obstet; 2012 Mar; 116(3):206-10. PubMed ID: 22189065
[TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
28. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
29. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy.
Koren G; Boskovic R; Hard M; Maltepe C; Navioz Y; Einarson A
Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S228-31. PubMed ID: 12011891
[TBL] [Abstract][Full Text] [Related]
30. Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
Spartinou A; Nyktari V; Papaioannou A
Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1289-1297. PubMed ID: 29057666
[TBL] [Abstract][Full Text] [Related]
31. Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.
Tuca A
Cancer Manag Res; 2009 Dec; 2():1-12. PubMed ID: 21188092
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study.
Lehmann AS; Renbarger JL; McCormick CL; Topletz AR; Rouse C; Haas DM
BMC Pregnancy Childbirth; 2013 Jun; 13():132. PubMed ID: 23786674
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the maternal-fetal transfer of granisetron in an ex vivo placenta perfusion model.
Julius JM; Tindall A; Moise KJ; Refuerzo JS; Berens PD; Smith JA
Reprod Toxicol; 2014 Nov; 49():43-7. PubMed ID: 25019977
[TBL] [Abstract][Full Text] [Related]
34. Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability.
Prentice HG
Support Care Cancer; 2003 Aug; 11(8):501-8. PubMed ID: 12845514
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
[TBL] [Abstract][Full Text] [Related]
36. Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm.
Mitchell-Jones N; Farren JA; Tobias A; Bourne T; Bottomley C
BMJ Open; 2017 Dec; 7(12):e017566. PubMed ID: 29222135
[TBL] [Abstract][Full Text] [Related]
37. Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
Adams LM; Johnson B; Zhang K; Yue L; Kirby LC; Lebowitz P; Stoltz R
Support Care Cancer; 2009 Sep; 17(9):1187-93. PubMed ID: 19205754
[TBL] [Abstract][Full Text] [Related]
38. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
Simmons K; Parkman HP
Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
Birch R; Weaver CH; Carson K; Buckner CD
Bone Marrow Transplant; 1998 Oct; 22(7):685-8. PubMed ID: 9818697
[TBL] [Abstract][Full Text] [Related]
40. Nausea and vomiting during pregnancy: a possible correlation with obsessive compulsive disorder and alexithymia.
Şahin B; Özçetinkaya Erdoğan S; Cura Şahin G; Karlı P; Kara OF; Hatırnaz Ş; Tinelli A
J Obstet Gynaecol; 2022 Jul; 42(5):929-934. PubMed ID: 34693875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
